Christina Friese

Herlev, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.

Journal: Frontiers in immunology

Published: July 09, 2024

Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.

Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.

Journal: Frontiers in immunology

Published: March 06, 2023

Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment.

Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment.

Journal: Oncoimmunology

Published: February 03, 2022

Inflammation induced PD-L1-specific T cells.

Inflammation induced PD-L1-specific T cells.

Journal: Cell stress

Published: October 28, 2019

Correction: Tumour-reactive T cell subsets in the microenvironment of ovarian cancer.

Correction: Tumour-reactive T cell subsets in the microenvironment of ovarian cancer.

Journal: British journal of cancer

Published: March 21, 2019

CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer.

CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer.

Journal: Scientific reports

Published: March 14, 2019

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer.

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer.

Journal: British journal of cancer

Published: March 12, 2018

SATB1 in Malignant T Cells.

SATB1 in Malignant T Cells.

Journal: The Journal of investigative dermatology

Published: November 23, 2017

Showing 1-8 of 8

Last Updated: 09/26/2026